Workplace impacts of anti-TNF therapies in rheumatoid arthritis: review of the literature

By Birnbaum Howard   Shi Lizheng   Pike Crystal   Kaufman Rebecca   Sun Peter   Cifaldi Mary  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. : 255-269

Informa Healthcare

Access to resources Recommend Favorite

Drug persistence, effectiveness and safety assessment of anti-TNF therapies in psoriatic arthritis

By Saad Amr A   Hyrich Kimme L   Ashcroft Darren M  

Expert Opinion on Drug Safety, Vol. 10, Iss. 2, 2011-03 ,pp. : 219-226

Informa Healthcare

Access to resources Recommend Favorite

Guidelines on the use of anti-tumour necrosis factor (TNF) therapies in patients with rheumatoid arthritis (RA) have been updated

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 475, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Emerging therapies for rheumatoid arthritis

By Jacques Peggy   Van den Bosch Filip  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 231-244

Informa Healthcare

Access to resources Recommend Favorite

Rheumatoid arthritis: developing pharmacological therapies

By Moreland Larry W   Misischia Richard J  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 7, 2002-07 ,pp. : 927-935

Informa Healthcare

Access to resources Recommend Favorite